We could look at it of one of two ways:
- Did Doug do good the last 12 months i.e. Hologic deals, FDA approval, BARDA deal and other expansions like HS and TF or;
- Given the share price tanked 60% over the same period, does it justify the bonuses.
Honestly, SP should be a reflection of bonuses earned - why should retail cop a loss of 60% over the last 12 months and management get a cool 6 figure payment?
If the SP remained flat and these deals were announced, probably a different story. Definitely a different story if the SP rose 60% on these announcements.
Ann: Notice of Annual General Meeting and Proxy Form, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 318288 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 45000 | 2 |
View Market Depth
| Last trade - 09.45am 18/06/2025 (20 minute delay) ? |
| LDX (ASX) Chart |
Day chart unavailable